Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Robert Lindell, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01223872
First received: October 15, 2010
Last updated: June 11, 2013
Last verified: June 2013

October 15, 2010
June 11, 2013
August 2010
June 2013   (final data collection date for primary outcome measure)
Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.
Same as current
Complete list of historical versions of study NCT01223872 on ClinicalTrials.gov Archive Site
  • Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints. [ Time Frame: pre-clinic and a post-clinic interviews at 1 and 3 months. ] [ Designated as safety issue: No ]
  • An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan. [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Scored responses will allow for quantitative analysis of differences within and between the cohorts of patients
  • A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    This data will be evaluated qualitatively for trends.
Same as current
Not Provided
Not Provided
 
Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
Childhood Cancer Survivors' Knowledge of Their Diagnosis, Treatment, and Risk of Late Effects: The Impact of Care in a Specialized Survivorship Clinic

This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.

Not Provided
Observational
Observational Model: Cohort
Not Provided
Not Provided
Non-Probability Sample

Fifty new cancer patients in the REACH for Survivorship clinic, fifty returning cancer patients in the REACH for Survivorship clinic, and one hundred routine care cancer patients are expected to enroll in this study.

Childhood Cancer
  • Other: interview
    • Standard Interview (2-15 years from last treatment)
    • Demographic data interview (pre-initial study interview)
  • Other: clinic visit and interview
    • REACH Clinic Visit(initial or regular)
    • Post-REACH Clinic Interview (3mos from initial or regular clinic visit)
    • Demographic data interview(pre-initial study interview)
  • Other: interviews and clinic visit
    • Pre-REACH Clinic Interview(2-15 yrs from last treatment)
    • REACH Clinic Visit(initial or regular)
    • Post-REACH Clinic Interview(1mo from initial clinic visit)
    • Post-REACH Clinic Interview(3mos from initial or regular clinic visit)
    • Demographic data interview(pre-initial study interview)
  • Routine Patient Care
    Intervention: Other: interview
  • Previously-enrolled REACH Clinic Patients
    Intervention: Other: clinic visit and interview
  • New REACH Clinic Patients
    Intervention: Other: interviews and clinic visit
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
160
August 2016
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Treatment for primary malignancy per risk-adapted protocol
  • Age ≤ 21 years at time of diagnosis
  • Currently alive without evidence of disease
  • Off therapy for no more than 15 years

Exclusion Criteria:

-Patients who have received a bone marrow transplant

Both
up to 21 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01223872
VICCREACH1038
No
Robert Lindell, Vanderbilt University
Vanderbilt University
Not Provided
Not Provided
Vanderbilt University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP